Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GTATTAAACCTTATTATCCAGAACATCTAGTTAATCATTACTTCCAAACTAGACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGA| |AACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAACAAGATCTACAGCATGGGGCAGAATCTTTCCACCAGCAATCCTCTGGGATTCTT
End
107275696/106659240 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/4226874; hsa-mir-10b/Downstream/2482250;
Upstream sequence
CCATTGCAGATCCTCCTCCAAACCGACTCCTGTGAAATATGACTGTAGGCAGGTCCCATCTGTTACTGTCCTGGCACCTAGGACCCCACCCAGCATGGAT
Downstream sequence
CCTCTTCCCATCACTCTTTCTTTCTCATCCAGCCTTCCCTACCCCCACCTATGCTCATCTTGCCTATTTTCTGGTTGACTGTTTACCACTCCTTTTACTC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.